Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland)The ...

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

The deal will reduce tariffs on pharmaceutical exports from Europe to India to zero from 11% for almost all products. This will also reduce input costs for specialized raw material that Indian firms ...

Americans are particularly concerned with avoiding animal products. Indeed, a recent study published in the Postgraduate ...

The House Budget Committee on Tuesday overwhelmingly approved a proposal aimed at lowering prescription drug prices in ...

Brazil’s health regulator Anvisa has recalled medicine batches and seized falsified products over packaging irregularities ...

Tariff cuts promise lower import costs, but patient prices may not fall overnight.

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

Drugmakers Sun Pharma, Cipla, Zydus and Graviti Pharmaceuticals are recalling different products in the U.S., most of them over manufacturing issues.